Oral LT4 is absorbed primarily in the small intestine, particularly in the jejunum and ileum, after dissolution in the stomach
symptoms include arterial hypotension, altered mental status, fever, tachycardia, and difficulty breathing, and more progressive disease results in multiorgan failure, which increases mortality risk (Peach, 2017
It is available in a generic formulation as ondansetron and is well known under the brand name, Zofran
Mendez-Sanchez N, Gonzalez V, Aguayo P, Sanchez JM, Tanimoto MA, Elizondo J, Uribe M
Scientists frequently investigate these peptides together because each influences different biological mechanisms associated with tissue repair